Search research articles
Contact Us
Filters
Showing results (11-20 of 276) with videos related to
Page
of 28
Sort By:
Translational Gastroenterology and Hepatology
|
December 22, 2017
Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for granted
Antonio Riccardo Buonomo, Ivan Gentile, Guglielmo Borgia
Expert Review of Anti-Infective Therapy
|
July 31, 2014
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia
Expert Opinion on Pharmacotherapy
|
May 13, 2026
The complexities of the Pharmacotherapeutic management of chronic hepatitis C virus infection in hepatocellular carcinoma patients
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
Infectious Diseases (London, England)
|
March 21, 2017
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet
Guglielmo Borgia, Alberto Enrico Maraolo, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
March 9, 2024
Personalized care approaches to hepatitis C therapy: recent advances and future directions
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2021
Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?
Giovanni de Simone, Saverio Stranges, Ivan Gentile
Critical Care (London, England)
|
December 7, 2021
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19"
Antonio Riccardo Buonomo, Giulio Viceconte, Ivan Gentile
Annals of Medicine
|
May 11, 2026
Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysis
Alberto Enrico Maraolo, Mariano Nobile, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Reviews on Recent Clinical Trials
|
June 3, 2014
Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Ivan Gentile, Antonio R Buonomo, Guglielmo Borgia
Page
of 28
Search research articles
Search
Showing results (11-20 of 276) with videos related to
Sort By:
Page
of 28
Translational Gastroenterology and Hepatology
|
December 22, 2017
Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for granted
Antonio Riccardo Buonomo, Ivan Gentile, Guglielmo Borgia
Expert Review of Anti-Infective Therapy
|
July 31, 2014
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia
Expert Opinion on Pharmacotherapy
|
May 13, 2026
The complexities of the Pharmacotherapeutic management of chronic hepatitis C virus infection in hepatocellular carcinoma patients
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
Infectious Diseases (London, England)
|
March 21, 2017
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet
Guglielmo Borgia, Alberto Enrico Maraolo, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
March 9, 2024
Personalized care approaches to hepatitis C therapy: recent advances and future directions
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2021
Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?
Giovanni de Simone, Saverio Stranges, Ivan Gentile
Critical Care (London, England)
|
December 7, 2021
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19"
Antonio Riccardo Buonomo, Giulio Viceconte, Ivan Gentile
Annals of Medicine
|
May 11, 2026
Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysis
Alberto Enrico Maraolo, Mariano Nobile, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Reviews on Recent Clinical Trials
|
June 3, 2014
Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Ivan Gentile, Antonio R Buonomo, Guglielmo Borgia
Page
of 28